Intacoxia 60 Tablet contains Etoricoxib 60mg, a selective cyclooxygenase-2 (COX-2) inhibitor used primarily for the management of pain and inflammation associated with various musculoskeletal and inflammatory conditions. Etoricoxib exerts its therapeutic effect by selectively inhibiting the COX-2 enzyme, thereby reducing the synthesis of prostaglandins involved in pain and inflammatory processes while sparing COX-1, which helps maintain gastrointestinal mucosal integrity. Intacoxia 60 is indicated for the relief of symptoms in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. It is also effective in managing chronic musculoskeletal pain and postoperative dental pain. The recommended dosage should be individualized based on the severity of the condition and patient response, with careful consideration of contraindications such as known hypersensitivity to Etoricoxib or other NSAIDs, active gastrointestinal bleeding, and severe hepatic or renal impairment. Patients with cardiovascular risk factors should use Intacoxia cautiously due to potential increased risk of thrombotic events. Common adverse effects may include headache, dizziness, gastrointestinal discomfort, and hypertension. Intacoxia 60 should be used under medical supervision, ensuring appropriate monitoring for efficacy and safety during treatment.